The Royal Marsden NHS Foundation Trust, a world-leading specialist cancer center, has partnered with NTT DATA and CARPL.ai to develop an advanced AI-powered radiology analysis service aimed at transforming cancer diagnosis and treatment. This cutting-edge platform, funded by a three-year grant from the UK’s National Institute for Health and Care Research (NIHR), supports research at The Royal Marsden and the Institute of Cancer Research (ICR), including collaborative projects focused on cancers such as sarcoma, lung, breast, brain, and prostate. The AI service enhances the speed and accuracy of identifying imaging biomarkers, enabling faster diagnoses, more precise evaluations, and better-targeted treatments.
Read More